Chinese Neuroscience Market

China Neurology Devices Market Analysis

The China Neurology Devices Market is expected to register a CAGR of 6.2% during the forecast period.

China Neurology Devices Market Trends

Cerebrospinal Fluid Management Segment is Expected to Show Better Growth in the Forecast Years

Based on type of device, it is segmented into cerebrospinal fluid management device, interventional neurology device, neurosurgery device, neurostimulation device and other type of devices. Cerebral spinal fluid (CSF) shunt systems are used to treat hydrocephalus, which is a common medical procedure and a life-saving treatment for many patients. These shunt systems drain excess fluid from the brain to another part of the body, where the fluid is absorbed as part of the circulatory process. The CSF imbalance can lead to elevated intracranial pressure (ICP), which can lead to a variety of complications. CSF shunts can be used to alleviate these problems in patients who suffer from hydrocephalus. The need for diagnosis and treatment of neurological disorders have made significant progress in recent years, which is expected to drive the market growth in the forecast period.

China Neurology Devices Industry Overview

The major players in the China neurology devices market are Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, MicroPort Scientific, Nihon Kohden Corporation, Smith & Nephew plc, and Stryker Corporation.

China Neurology Devices Market Leaders